Cargando…

Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia

Inflammation underpins aspects of insulin resistance and dysglycemia. Microbiota-derived cell wall components such as muropeptides or endotoxin can trigger changes in host immunity and metabolism. Specific peptidoglycan motifs promote metabolic tissue inflammation, lipolysis and insulin resistance v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duggan, Brittany M., Foley, Kevin P., Henriksbo, Brandyn D., Cavallari, Joseph F., Tamrakar, Akhilesh K., Schertzer, Jonathan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431485/ https://www.ncbi.nlm.nih.gov/pubmed/28484277 http://dx.doi.org/10.1038/s41598-017-01822-0

Ejemplares similares

Inflammation promotes adipocyte lipolysis via IRE1 kinase
por: Foley, Kevin P., et al.
Publicado: (2021)

Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1
por: Chi, Wendy, et al.
Publicado: (2014)

Gut microbiota impairs insulin clearance in obese mice
por: Foley, Kevin P., et al.
Publicado: (2020)

Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice
por: Rebalka, Irena A., et al.
Publicado: (2017)

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
por: Pierotti, Catia L., et al.
Publicado: (2023)

Dysglycemia and arrhythmias
por: Sun, Dong-Kun, et al.
Publicado: (2023)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015)

Gut microbiota-based vaccination engages innate immunity to improve blood glucose control in obese mice
por: Duggan, Brittany M., et al.
Publicado: (2021)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

Dysglycemia in young women attenuates the protective effect against fatty liver disease
por: Pérez-Montes de Oca, Alejandra, et al.
Publicado: (2022)

Impact of cell wall encapsulation of almonds on in vitro duodenal lipolysis
por: Grundy, Myriam M.L., et al.
Publicado: (2015)

Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation
por: Tu, Hailin, et al.
Publicado: (2022)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Zhang, Xixi, et al.
Publicado: (2019)

Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
por: Takiishi, Tatiana, et al.
Publicado: (2023)

Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans
por: Chassaing, Benoit, et al.
Publicado: (2017)

Dysglycemia and a History of Reproductive Risk Factors
por: McDonald, Sarah D., et al.
Publicado: (2008)

Dysglycemia and Arthroplasty Outcomes: A Review
por: Alkindy, Talal
Publicado: (2020)

Dysglycemia in Pregnancy and Maternal/Fetal Outcomes
por: Silva, Corinne M., et al.
Publicado: (2021)

Insulin as a Tool in Factitious Dysglycemia
por: Odhaib, Samih A, et al.
Publicado: (2021)

Discovery of a cooperative mode of inhibiting RIPK1 kinase
por: Meng, Huyan, et al.
Publicado: (2021)

Targeting RIPK1 kinase for modulating inflammation in human diseases
por: Li, Wanjin, et al.
Publicado: (2023)

Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome
por: Jarrett, Brittany Y, et al.
Publicado: (2019)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
por: Moujalled, D M, et al.
Publicado: (2013)

Long term but not short term exposure to obesity related microbiota promotes host insulin resistance
por: Foley, Kevin P., et al.
Publicado: (2018)

Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation
por: Muendlein, Hayley I., et al.
Publicado: (2020)

Dysglycemia induces abnormal circadian blood pressure variability
por: Kumarasamy, Sivarajan, et al.
Publicado: (2011)

Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2021)

Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis
por: Remijsen, Q, et al.
Publicado: (2014)

Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018)

T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway
por: Wei, Bo, et al.
Publicado: (2022)

Association of In-Hospital Mortality and Dysglycemia in Septic Patients
por: Chao, Hsiao-Yun, et al.
Publicado: (2017)

LDL Cholesterol and Dysglycemia: an Intriguing Physiological Relationship
por: Merino, Jordi, et al.
Publicado: (2020)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance
por: Denou, Emmanuel, et al.
Publicado: (2015)

Correction to: Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study
por: Ma, Haoming, et al.
Publicado: (2022)

Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis
por: Someda, Masataka, et al.
Publicado: (2019)

Postbiotics engage IRF4 in adipocytes to promote sex‐dependent changes in blood glucose during obesity
por: Duggan, Brittany M., et al.
Publicado: (2022)

RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
por: Jhun, Jooyeon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_haok5uj6cdt3423jqgr3tss0ja